文献速递消化道肿瘤放疗放疗物理与技术

胰腺癌术中放疗(IORT)研究综述

Intraoperative radiation therapy (IORT) in pancreatic cancer.
PubMed 文献 · Radiat Oncol · 2017-01-10

本文综述胰腺癌术中放疗(IORT)在多学科管理中的应用。胰腺癌术后局部失败率高达50-80%,邻近关键结构限制外照射剂量,IORT可向高危区域递送高剂量并保护危及器官。

要点

  • 胰腺癌术后局部失败率高达50-80%
  • 邻近骨髓、脊髓、肾、肝、肠等限制外照射剂量
  • IORT可向微观病灶高危区递送高剂量并保护危及器官

核心结论

  • IORT是胰腺癌多学科管理中具有潜力的治疗策略,可提高肿瘤治疗指数并减少放射性毒性。

研究设计与样本

  • 本文为综述,旨在更新并评论IORT在胰腺癌多学科管理中的作用。

主要发现

  • 即使切除后胰腺癌局部失败率仍高达50-80%。
  • 邻近骨髓、脊髓、肾、肝和肠等关键结构限制外照射可给予肿瘤床的剂量。
  • IORT可向微观病灶高危区域递送高剂量,同时保护关键器官并减少放射性毒性可能。

临床怎么用

  • IORT可作为胰腺癌多学科管理中的治疗策略,用于向高危区域递送高剂量并保护危及器官。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite the important improvements made in the fields of surgery, chemotherapy and radiation therapy, pancreatic cancer remains one of the most lethal malignancies. Improved outcomes with novel chemotherapy regimes led again to increased attention on the role of localized radiotherapy, since local tumor progression causes significant morbidity and mortality in patients. Even after resection local failure rates are as high as 50-80%. The immediate proximity to critical structures (bone marrow, spinal cord, kidneys, liver, and intestine) limits the dose of radiation that can be administered to the tumor bed with conventional external beam radiation therapy (EBRT). The intraoperative radiotherapy (IORT) appears to be an ideal therapeutic strategy for this disease, having the advantage of enabling the delivery of high doses of radiation to areas that are at risk for microscopic disease, saving critical organs and reducing the possibility of inducing radiotoxicity. This technique allows a theoretical increase in the radiation therapeutic index to tumor compared to the adjacent organs at risk (OAR). The aim of this review is to update and comment on IORT in the multidisciplinary management of pancreatic cancer.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Krempien R, Roeder F. Intraoperative radiation therapy (IORT) in pancreatic cancer. Radiat Oncol. 2017. PMID: 28069018. doi:10.1186/s13014-016-0753-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。